RxDoctor Payments Data

Joshua Foster, DO

Psychiatry · Maryville, MONPI 1700447190

Payments from drug & device makers

$699in general payments, 2019–2025

Across 41 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$157
  • AbbVie$96
  • Neurocrine Biosciences, Inc.$77
  • Alkermes, Inc.$72
  • Teva Pharmaceuticals USA, Inc.$66
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$54
  • plus $176 from 7 others

What the payments were for

  • Food & beverage$699100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$699 in reported general payments places this provider in the 65th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri

Medicare billing

Part B allowed, 2024
$53,306
Medicare patients
100
Services billed
819

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate24$77,375
NuplazidPimavanserin Tartrate14$69,965
VivitrolNaltrexone Microspheres12$19,656
Oxcarbazepine37$3,655
Chlorpromazine Hcl28$3,608
Lisdexamfetamine Dimesylate15$3,350
Aripiprazole32$1,907
Paliperidone ErPaliperidone23$1,467
Quetiapine Fumarate78$1,261
Risperidone OdtRisperidone12$1,183
Gabapentin32$1,047
Buspirone Hcl50$917
Venlafaxine Hcl ErVenlafaxine Hcl58$898
Trazodone Hcl115$861
Risperidone45$782

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$157$77,37524 claims
Alkermes, Inc.Vivitrol$72$19,65612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 680 psychiatry providers in Missouri.

Other psychiatry in Maryville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →